Thanks HDG, always appreciate your insights. You are right that the regulatory review process is not as straightforward in EU w/ the various clock stops for questions, etc. But your projections look spot on to me.
Do you think Amarin intentionally delayed the EU submission to defer having to make a decision on an EU partner (and also to maximize their value to a potential buyer?).